Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02805712
Other study ID # 2014P001391
Secondary ID
Status Completed
Phase N/A
First received May 20, 2016
Last updated July 19, 2017
Start date September 2014
Est. completion date December 1, 2016

Study information

Verified date July 2017
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on documentation of advanced care planning and end of life preferences, symptom burden, quality of life and health care utilization.


Description:

Patients will be assigned to one of two groups a) longitudinal goals of care discussion led by a palliative care-trained social worker or b) usual care + written information regarding advanced directives. The intervention group will be enrolled in the hospital and then be followed longitudinally for 3 months by a palliative care-trained social worker who will shepherd a conversation around prognosis, expectations, and goals of care. The results of these conversations will be documented in the electronic medical record and shared with the clinical team. Clinical symptoms that are identified during these conversations will be evaluated by a Palliative Care Physician who will relay suggestions regarding management to the primary treating clinician. Baseline surveys will assess prognostic awareness, symptom burden, anxiety, depression, and quality of life for both groups. At the conclusion of the study, an individualized follow-up plan will be devised for each patient based on a needs assessment by the study social worker.

Patients assigned to the control/usual care arm will complete the same series of questionnaires as those assigned to the intervention group and will undergo usual in hospital and post-discharge treatment as directed by their care team. All control subjects will receive written Advanced Care planning and Heart Failure education materials as provided routinely to inpatients at Brigham and Women's Hospital. At the 6 month visit following hospitalization, these patients will be asked to complete follow up questionnaires and then will be given the option to participate in the above verbal intervention and guided "Goals and Values" conversation that was provided to the intervention group.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 1, 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria

- Symptomatic Heart Failure (NYHA II-IV)

- Hospitalized or recently for acute decompensation with at least one of the following high-risk features

- Prior hospitalization for Heart Failure (HF) within 1 year

- Age > 80 years

- Chronic Kidney Disease (estimated Glomerular Filtration Rate (eGFR) < 45 mL/min/m2)

- Systolic Blood Pressure < 100 mm Hg

- Serum sodium < 130 meq/L

- Cardiogenic Shock (Cardiac Index < 2.0)

- Serious Non-Cardiovascular Illness (e.g. advanced stage cancer, Chronic Obstructive Pulmonary Disease (COPD) , or the like.

- Ability to Provide Informed Consent

- Permission of attending physician

Exclusion Criteria

- Anticipated major cardiac surgery, including Ventricular Assist Device (VAD) or transplant, within 3 months of enrollment

- Already enrolled in hospice or receiving outpatient palliative care

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Verbal Information and Discussion
Intervention patient will receive a outpatient session with a palliative care social worker in the heart failure clinic two weeks post discharge consent focusing on goals of care.
Control
The control group will receive usual written care material and a palliative care consult if ordered by physician.

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Is there a change in patient understanding of prognosis with the addition of a palliative care intervention? Assessment tool: Patient Preferences Questionnaire. 6 months
Secondary Is there an impact on documentation of advanced care planning documentation with a palliative care intervention? Chart review of Advanced Care Planning documents and written notes by members of clinical team. 6 months
Secondary Is there an impact on symptom burden through a palliative care intervention? Assessment tool: : The Kansas City Cardiomyopathy Questionnaire (KCCQ-12) Three months
Secondary Is there an impact on perceived level of illness through a palliative care intervention? Assessment tool: EQ visual analogue scale (EQ-VAS) 6 months
Secondary Is there an impact on overall patient well being through a palliative care intervention? Assessment tool: The Functional Assessment of Chronic Illness Therapy ( FACIT-Sp) Three months
Secondary Is there an impact on depression through a palliative care intervention? Assessment tool: Patient Health Questionnaire (PHQ-8) 6 months
Secondary Is there an impact on anxiety through a palliative care intervention? Assessment tool: General Anxiety Disorder (GAD-7) 6 months
Secondary Is there an impact on cost of treatment through a palliative care intervention? Focus will be on cost through health care utilization as aggregated by number of hospital days, days in ICU and 30 day re-admissions. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy